Johnson & Johnson Boosters Recommended by FDA Advisers
1 Min Read
19-0 of the FDA's Vaccines and Related Biological Products Advisory Committee voted on the extra dose.
-
Dr. Anthony Fauci has recommended the flu shot with the Covid shot
The Food and Drug Administration (FDA) vaccine advisory group voted Friday to officially endorse a Johnson&Johnson booster shot.
On the question of mix and match boosters - taking a booster shot from a brand differing from the original immunization - the FDA's Vaccines and Related Biological Products Advisory (VRBPAC) Committee was asked to consider the possibility.
Anyone over 18 with an initial dose of Johnson&Johnson is recommended to have a second shot at least two months after the first.
Many committee members believe it should be a two-dose vaccination, similar to Moderna and Pfizer.
Prior to their meeting, the FDA's scientists issued a briefing document indicating that a benefit for J&J boosters appeared promising.
The US Centers for Disease Control and Prevention's vaccine advisers will be asked to consider it.
According to studies by Johnson&Johnson, a booster shot after two or six months can boost the effectiveness of prevention by up to 94%.
